Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Urothelial Cancer

Clinical Trial at: Texas Oncology - Odessa

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

500 W 3rd St
Odessa, Texas 79761
524.03 mi. away
P: (432) 335-8275

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Odessa

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

500 W 3rd St
Odessa, Texas 79761
524.03 mi. away
P: (432) 335-8275

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Odessa

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

500 W 3rd St
Odessa, Texas 79761
524.03 mi. away
P: (432) 335-8275

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Odessa

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

500 W 3rd St
Odessa, Texas 79761
524.03 mi. away
P: (432) 335-8275

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CLEE011O12301C (TRIO033): A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE).

  • Details

ClinicalTrials.gov ID: NCT03701334
Diagnosis Type: NA
USOR Number: 19058

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Skin Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A Phase I, Multi-Center, Open-Label, Treatment Duration Increment, Expansion, Safety, and Pharmacodynamic Study of CX-4945 Administered Orally Twice Daily to Patients with Advanced Basal Cell Carcinoma (CX-4945-07)

  • Details

ClinicalTrials.gov ID: NCT03897036
Diagnosis Type: NA
USOR Number: 18014

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors

  • Details

ClinicalTrials.gov ID: NCT03369223
Diagnosis Type: NA
USOR Number: 18057

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

  • Details

ClinicalTrials.gov ID: NCT04285567
Diagnosis Type: CLL
USOR Number: 19182

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL, CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ATEZOLIZUMAB GIVEN IN COMBINATION WITH CABOZANTINIB VERSUS DOCETAXEL MONOTHERAPY IN PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH AN ANTI PD-L1/PD-1 ANTIBODY AND PLATINUM-CONTAINING CHEMOTHERAPY (GO41892)

  • Details

ClinicalTrials.gov ID: NCT04471428
Diagnosis Type: NA
USOR Number: 20142

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Uterine Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

1700 S Potomac Street
Aurora, Colorado 80012
524.66 mi. away
P: (303) 418-7600

More Details View Practice Page

Pages